CRTC1-MAML2 gene fusion in mucoepidermoid carcinoma of the lacrimal gland

Keyphrases

• Lacrimal Gland 100%
• Mucoepidermoid Carcinoma 100%
• Gene Fusion 100%
• MAML2 Gene 100%
• CRTC1-MAML2 100%
• Lacrimal 50%
• Tumor 33%
• Quantitative PCR 16%
• Immunohistochemistry 16%
• 5-year Follow-up 16%
• Tumor Cells 16%
• Older Men 16%
• Salivary Gland 16%
• Favorable Prognosis 16%
• Anatomical Location 16%
• Lung 16%
• Cervix 16%
• Prognostic Biomarker 16%
• Neoplasms 16%
• Fusion Protein 16%
• Diagnostic Biomarker 16%
• Thyroid Gland 16%
• Genetic Similarity 16%
• Epithelial Tumor 16%
• Recurrence or Metastasis 16%
• Exocrine Glands 16%
• Salivary Gland Tumor 16%
• Microscopic Appearance 16%

Medicine and Dentistry

• Lacrimal Gland 100%
• Mucoepidermoid Carcinoma 100%
• Gene Fusion 100%
• Neoplasm 50%
• Diagnosis 16%
• Cervix 16%
• Biological Marker 16%
• Metastatic Carcinoma 16%
• Morphology 16%
• Tumor Cell 16%
• Immunohistochemistry 16%
• Recurrent Disease 16%
• Salivary Gland 16%
• Thyroid Gland 16%
• Reverse Transcription Polymerase Chain Reaction 16%
• Fusion Protein 16%
• Biological Product 16%
• Epithelioma 16%
• Salivary Gland Neoplasm 16%
• Exocrine Gland 16%